pillbase.ru

Ojjaara

Active substance: momelotinib

TABLET · MOMELOTINIB DIHYDROCHLORIDE MONOHYDRATE 200 mg/1

United StatesActive

Marketing holder: GlaxoSmithKline LLC

Verified 2026-10-09 · openFDA NDC

Analogues in other countries
Analogues by country

Products with the same active substance registered in other countries.

CountryProducts
EU 1
  • Omjjara
    Momelotinib dihydrochloride monohydrate
    EMEA/H/C/005768
    GlaxoSmithKline Trading Services Limited
Import and control

Control by country

  • United Statesprescription only

    Source: openFDA NDC · record 01a1208c-3661-7e42-a0c4-b2df1a4cdba7,01a1208c-d9dd-79b8-8770-8541a93223cf,01a1209c-5170-7a7b-8b61-aa9ffce49378;count=3 · valid from 2026-10-09 · verified 2026-10-09

More on control status
Registration
Registration number
81864-101
Registration status
Active
Dispensing
Prescription only
Route
ORAL
Sources
  • product · openFDA NDC · 81864-101 · Verified 2026-10-09 · open in source
  • registration_status · openFDA NDC · 81864-101 · Verified 2026-10-09 · open in source
  • ingredients.0 · openFDA NDC · 81864-101 · Verified 2026-10-09 · open in source